CHRISTIANSON MARK (Business Development Director) reported 1 transaction at NEUROONE MEDICAL TECHNOLOGIES CORP
Review the transaction codes below to understand the nature of each event.
Filed: 4/2/2025ACC: 0001709738-25-000003
Officer· Business Development Director
Since Feb 2026
-253.00
Net shares
Net seller
$215.10
Total sold
0
Open market trades
0B · 0S
1
Total transactions
253.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−253.00
Price / share
$0.85
Trade value
$215.10
% of position
0.1%
3/31/2025
291.74K→291.49K
Total
Net shares
−253.00
Net value
-$215.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | F · Tax Withholding | −253.00 | $0.85 | $215.10 | 0.1% | 291.74K | 291.49K |
| Total | −253.00 | -$215.10 | ||||||
Derivative Transactions0
No derivative transactions reported